|
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial |
|
|
|
Titel: |
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial |
Auteur: |
Peng, Zikun Li, Huayi Gao, Yunong Sun, Li Jiang, Jie Xia, Bairong Huang, Yi Zhang, Yu Xia, Yu Zhang, Yuxin Shen, Yiyang Huang, Bowen Nie, Jiayu Chen, Xinrong Liu, Xingyu Feng, Cui Li, Zhen Zhang, Wei Tao, Kangjia Zhang, Qiuxue Duan, Shican Chen, Yaheng Chen, Yeshan Wang, Wei Zheng, Hong Lu, Yudong Liu, Yi Wang, Limei Qi, Wencai He, Yang Tian, Yan Li, Guiling Ma, Ding Gao, Qinglei |
Verschenen in: |
Lancet oncology |
Paginering: |
Jaargang 25 () nr. 10 pagina's 1288-1297 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|